Gadoversetamide

In the US, Gadoversetamide is a member of the drug class magnetic resonance imaging contrast media and is used to treat Magnetic Resonance Angiography.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V08CA06

CAS registry number (Chemical Abstracts Service)

0131069-91-5

Chemical Formula

C20-H34-Gd-N5-O10

Molecular Weight

661

Therapeutic Category

Diagnostic agent

Chemical Names

[N,N-Bis[2-[[(carboxymethyl)[(2-methoxyethyl)carbamoyl]methyl]amino]ethyl]glycinato(3-)]gadolinium (WHO)

Gadolinium, [8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)]- (USAN)

Foreign Names

• Gadoversetamidum (Latin)
• Gadoversetamid (German)
• Gadoversetamide (French)
• Gadoversetamida (Spanish)

Generic Names

• Gadoversetamide (OS: BAN, USAN)
• MP 1177 (IS: MallinckrodtMe)
• Gadoversetamide (PH: USP 32)

Brand Names

• OptiMARK
  Covidien, Austria; Covidien, Belgium; Covidien, Luxembourg; Covidien Deutschland, Greece; Mallinckrodt, Argentina; Mallinckrodt, United States; Tyco, Canada; Tyco, Denmark; Tyco, Norway; Tyco Healthcare, Slovenia



• Optimark
  Covidien, Sweden



• Optimark (Gadoversetamide and Gadoversetamide)
  Mallinckrodt, Switzerland



• Optimark (Gadoversetamide and Versetamide)
  Mallinckrodt, Switzerland

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.